Magainin 1 is an antimicrobial peptide discovered in the skin of Xenopus laevis.
CAT No: R1499
CAS No:108433-99-4
Synonyms/Alias:Magainin 1;magainin 1 peptide, Xenopus;Magainin 1, Xenopus;Magainin I;108433-99-4;FM73476;DA-55171;magainin 1 peptide, Xenopus, Meganin 1, CHEMBL409372, LS-186859, LS-187515, J-002140, 108433-99-4;
Magainin 1 is a naturally occurring antimicrobial peptide originally isolated from the skin of the African clawed frog, Xenopus laevis, and is renowned for its broad-spectrum activity against bacteria, fungi, and certain protozoa. As a member of the magainin family, this amphipathic, cationic peptide is characterized by its ability to interact with and disrupt microbial membranes, making it a valuable model for innate immune defense mechanisms. Its distinctive structural properties and functional versatility have positioned it as a key compound in biochemical research, particularly in studies related to host-pathogen interactions, membrane biophysics, and the development of novel antimicrobial strategies.
Antimicrobial mechanism studies: Magainin 1 is widely used as an investigative tool in elucidating the molecular basis of peptide-mediated membrane disruption. Researchers employ it to probe the biophysical interactions between cationic peptides and lipid bilayers, enabling detailed analysis of pore formation, membrane permeabilization, and the selectivity of antimicrobial action. These studies contribute to a deeper understanding of innate immunity and inform the rational design of next-generation antimicrobial agents.
Membrane biophysics research: The peptide serves as a model system for examining the structural and functional dynamics of amphipathic helices within biological membranes. Through techniques such as circular dichroism spectroscopy, solid-state NMR, and fluorescence assays, scientists utilize magainin 1 to investigate peptide-lipid interactions, membrane curvature induction, and the energetics of peptide insertion. Insights gained from such research advance knowledge in the fields of membrane protein folding, peptide aggregation, and lipid domain organization.
Peptide engineering and design: Magainin 1 provides a valuable template for the rational design and optimization of synthetic antimicrobial peptides. By systematically modifying its amino acid sequence, researchers assess the impact of structural changes on antimicrobial potency, stability, and specificity. This iterative process aids in developing custom peptides with enhanced activity or selectivity profiles, supporting applications in biotechnology, food safety, and material science.
Functional assays and screening: In biochemical and microbiological laboratories, magainin 1 is frequently used as a positive control or reference compound in antimicrobial activity assays. Its well-characterized bioactivity allows for the benchmarking of new peptide candidates, high-throughput screening of compound libraries, and validation of assay protocols. The reproducibility and robustness of its effects make it a standard tool in antimicrobial research workflows.
Host-pathogen interaction models: The peptide is also employed in experimental systems designed to simulate innate immune responses or to model the interactions between host defense molecules and invading pathogens. By incorporating magainin 1 into in vitro or ex vivo assays, investigators can dissect the mechanisms by which antimicrobial peptides modulate microbial viability, biofilm formation, and immune signaling pathways. Such studies provide critical insights into the evolutionary dynamics of host defense and microbial resistance, informing both fundamental research and applied innovation in infectious disease biology.
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.